(Q53770536)

19 May 2018

review article

1 reference

title

Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995. (English)

1 reference

19 May 2018

Hormone Replacement Therapy

main subject

1 reference

J H Pickar

1

1 reference

19 May 2018

I Thorneycroft

series ordinal

2

1 reference

19 May 2018

M Whitehead

series ordinal

3

1 reference

19 May 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

19 May 2018

American Journal of Obstetrics and Gynecology

published in

1 reference

19 May 2018

volume

178

1 reference

19 May 2018

issue

5

1 reference

19 May 2018

page(s)

1087-1099

1 reference

19 May 2018

Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Endometrial effects during hormone replacement therapy with a sequential oestradiol valerate/cyproterone acetate preparation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Comparison of Continuous Versus Sequential Estrogen and Progestin Therapy in Postmenopausal Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Continuous estrogen/progestin therapy in menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Benefits and risks of different hormonal replacement therapies in post-menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

The effect of desogestrel for hormone replacement therapy on the blood lipid profiles of postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins, and HDL subfractions in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

A comparison of the effects of lipoproteins of two progestogens used during cyclical hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

The effects of conjugated equine estrogens plus cyclical dydrogesterone on serum lipoproteins and apoproteins in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Effect on plasma lipids and lipoproteins of postmenopausal oestrogen therapy with added dydrogesterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Effects of medrogestone and conjugated oestrogens on serum lipid and lipoprotein concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Effect of progestogens on estrogen-induced lipoprotein changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Changes in Plasma Lipoprotein and Apolipoprotein Composition in Relation to OralVersusPercutaneous Administration of Estrogen Alone or in Cyclic Association with Utrogestan in Menopausal Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Hormone replacement therapy: lipid responses to continuous combined oestrogen and progestogen versus oestrogen monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Effects of cyproterone acetate (CPA) on serum lipoproteins when administered alone and in combination with ethinyl estradiol (EE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Influence of menopause on serum lipids and lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Menopause and risk factors for coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Estrogen and coronary heart disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Lp(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Associations of serum lipid concentrations and obesity with mortality in women: 20 year follow up of participants in prospective population study in Gothenburg, Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Lipoprotein and apolipoprotein levels in postmenopausal women on continuous oestrogen/progestogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970553-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9378(98)70553-8

1 reference

19 May 2018

1 reference

19 May 2018